US Bancorp DE reduced its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 23.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 27,844 shares of the company’s stock after selling 8,333 shares during the period. US Bancorp DE’s holdings in Option Care Health were worth $938,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Assetmark Inc. grew its holdings in Option Care Health by 13.2% during the fourth quarter. Assetmark Inc. now owns 109,180 shares of the company’s stock worth $3,678,000 after buying an additional 12,772 shares in the last quarter. CreativeOne Wealth LLC purchased a new position in Option Care Health during the 4th quarter worth $294,000. Quest Partners LLC bought a new stake in shares of Option Care Health in the 4th quarter worth $105,000. Corient Private Wealth LLC raised its holdings in shares of Option Care Health by 16.8% in the fourth quarter. Corient Private Wealth LLC now owns 24,513 shares of the company’s stock valued at $826,000 after purchasing an additional 3,529 shares during the last quarter. Finally, Philadelphia Trust Co. bought a new position in shares of Option Care Health during the fourth quarter valued at about $674,000. 98.05% of the stock is owned by hedge funds and other institutional investors.
Option Care Health Stock Performance
Shares of OPCH stock opened at $30.32 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.39 and a current ratio of 1.77. The firm has a market cap of $5.27 billion, a price-to-earnings ratio of 19.95, a P/E/G ratio of 1.45 and a beta of 1.31. Option Care Health, Inc. has a 52 week low of $26.17 and a 52 week high of $35.74. The firm’s 50-day simple moving average is $30.51 and its two-hundred day simple moving average is $31.49.
Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The company had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter in the previous year, the firm posted $0.21 EPS. Option Care Health’s revenue was up 12.8% on a year-over-year basis. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.19 earnings per share for the current year.
Analyst Upgrades and Downgrades
OPCH has been the subject of several analyst reports. Jefferies Financial Group increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 24th.
Read Our Latest Stock Analysis on Option Care Health
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Receive News & Ratings for Option Care Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Option Care Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
